” said François Roberge, President and CEO of LSL Pharma Group. “The acceleration of production at LSL Laboratories (“LSL”) is progressing according to plan, following the move to new facilities in La Pocatière earlier
” stated François Roberge, President and Chief Executive Officer of LSL Pharma Group. “The priority, after all, is safeguarding the health and well-being of vulnerable newborns. This opportunity is a testament to the solid reputation that...
LSL PHARMA GROUP INC. (TSXV: LSL) (the "Corporation" or "LSL Pharma "), a Canadian integrated pharmaceutical company, today reported its financial results for the first quarter of fiscal year 2024 ended on March 31, 2024.
BOUCHERVILLE, Québec, Dec. 08, 2023 (GLOBE NEWSWIRE) --LSL Pharma Group Inc.(TSXV: LSL) – (the “Company” or “LSL Pharma Group”), a Canadian integrated pharmaceutical company, is pleased to announce that the Company has closed the second tranche of its brokered priva...